Aspira Womens Health Inc (AWH)
3.21
0.00 (0.00%)
USD |
NASDAQ |
May 03, 16:00
3.21
0.00 (0.00%)
After-Hours: 20:00
Aspira Womens Health Net Income (Quarterly): -3.089M for Dec. 31, 2023
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -3.089M |
| September 30, 2023 | -4.706M |
| June 30, 2023 | -2.317M |
| March 31, 2023 | -6.067M |
| December 31, 2022 | -4.591M |
| September 30, 2022 | -7.783M |
| June 30, 2022 | -8.243M |
| March 31, 2022 | -9.268M |
| December 31, 2021 | -8.961M |
| September 30, 2021 | -9.707M |
| June 30, 2021 | -7.074M |
| March 31, 2021 | -5.92M |
| December 31, 2020 | -6.081M |
| September 30, 2020 | -4.287M |
| June 30, 2020 | -3.831M |
| March 31, 2020 | -3.706M |
| December 31, 2019 | -3.387M |
| September 30, 2019 | -3.82M |
| June 30, 2019 | -4.314M |
| March 31, 2019 | -3.716M |
| December 31, 2018 | -2.82M |
| September 30, 2018 | -2.652M |
| June 30, 2018 | -3.049M |
| March 31, 2018 | -2.85M |
| December 31, 2017 | -2.955M |
| Date | Value |
|---|---|
| September 30, 2017 | -2.509M |
| June 30, 2017 | -2.36M |
| March 31, 2017 | -2.673M |
| December 31, 2016 | -2.846M |
| September 30, 2016 | -3.476M |
| June 30, 2016 | -3.749M |
| March 31, 2016 | -4.897M |
| December 31, 2015 | -4.983M |
| September 30, 2015 | -5.146M |
| June 30, 2015 | -4.849M |
| March 31, 2015 | -4.137M |
| December 31, 2014 | -4.076M |
| September 30, 2014 | -5.591M |
| June 30, 2014 | -5.555M |
| March 31, 2014 | -3.987M |
| December 31, 2013 | -1.817M |
| September 30, 2013 | -2.314M |
| June 30, 2013 | -2.117M |
| March 31, 2013 | -2.571M |
| December 31, 2012 | -1.375M |
| September 30, 2012 | -2.021M |
| June 30, 2012 | -1.974M |
| March 31, 2012 | -1.776M |
| December 31, 2011 | -3.135M |
| September 30, 2011 | -4.651M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
-9.707M
Minimum
Sep 2021
-2.317M
Maximum
Jun 2023
-5.640M
Average
-4.706M
Median
Sep 2023
Net Income (Quarterly) Benchmarks
| Bruker Corp | 50.90M |
| Azenta Inc | -15.72M |
| Harvard Bioscience Inc | -1.818M |
| Bionano Genomics Inc | -43.89M |
| Akoya Biosciences Inc | -10.80M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 2.13M |
| Total Expenses (Quarterly) | 6.265M |
| EPS Diluted (Quarterly) | -0.30 |
| Enterprise Value | 39.29M |
| Gross Profit Margin (Quarterly) | 57.23% |
| Profit Margin (Quarterly) | -145.0% |
| Earnings Yield | -55.76% |
| Normalized Earnings Yield | -61.09 |